戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 pase normalized along with resolution of the pseudocyst.
2 sm was performed after the resorption of the pseudocyst.
3 c MR finding for the diagnosis of pancreatic pseudocyst.
4 ean interval of 42.7 days after diagnosis of pseudocyst.
5 normalities that can be seen with pancreatic pseudocyst.
6 ific proteins and a formation of subpodocyte pseudocyst.
7 ccess of percutaneous drainage of pancreatic pseudocyst.
8  pancreatitis (MPD > 7 mm) and an associated pseudocyst.
9 nerable macula, marked by the development of pseudocysts.
10 -KO mouse myocardium contained more parasite pseudocysts.
11 , late bacteriologic changes, abscesses, and pseudocysts.
12 st 3 months were categorized as degenerative pseudocysts.
13 classified 302 IRF cysts and 85 degenerative pseudocysts.
14  description of a melanocytoma with multiple pseudocysts.
15 ta for differentiating cystic neoplasms from pseudocysts.
16 nflammation, necrosis, fibrosis, and T cruzi pseudocysts.
17 l stay than surgical treatment of pancreatic pseudocysts.
18 pancreas developed in 22 patients (1.8%): 12 pseudocysts, 2 cysts/remnants, 4 intraductal papillary m
19  neoplasm (15%), chronic pancreatitis (14%), pseudocyst (3%), and trauma (3%).
20 isease (4 patients), 2) localized abscess or pseudocyst (6 patients), or 3) severe disease (11 patien
21 18%), neuroendocrine tumor (14%), pancreatic pseudocyst (6%), cystadenocarcinoma (3%), and miscellane
22 ntial agent of persistent infections is the 'pseudocyst', a spherical form of T. vaginalis identified
23 vere acute ischemic pancreatitis, pancreatic pseudocyst, abdominal aortic aneurysm, generalized ather
24 ical ventilation, 109 (26%) of 422 developed pseudocysts, acute insulin therapy was needed in 81 (21%
25 ter 19 weeks with no evidence of a recurrent pseudocyst and a normal serum amylase level.
26 astric mass include hepatomegaly, pancreatic pseudocyst and epigastric hernia, less common causes bei
27 tients who underwent operative management of pseudocyst and fluid collections as their sole mode of i
28 ur report focuses on these complications and pseudocysts and on the surgical management.
29                                   Pancreatic pseudocysts and peripancreatic fluid collections associa
30 ditional robust and reproducible research on pseudocysts and persistent T. vaginalis infections is re
31                 Although many cysts, such as pseudocysts and serous cystadenomas, are benign and can
32 c fluid collections include hematoma/seroma, pseudocyst, and abscess.
33 as and three inflammatory), one had a benign pseudocyst, and one had abundant inflammatory cells on R
34 s, two peripancreatic fluid collections, one pseudocyst, and one intra-abdominal abscess; two donors
35 4 (9.4%) were acute collections, 178 (49.3%) pseudocysts, and 149 (41.3%) walled-off necrosis (WON).
36 o have debris by either or both readers were pseudocysts, and only one (4%) of the 22 cystic neoplasm
37 s of subchondral bone thickness, subchondral pseudocysts, and osteophytes.
38 creatic fluid collections are referred to as pseudocysts; and acute necrotic collections, as walled-o
39                                   Pancreatic pseudocysts are a common complication of pancreatitis, a
40       Outer retinal defects and intraretinal pseudocysts are associated with an increased risk of MH
41                                   Pancreatic pseudocysts are collections of inflammatory fluid associ
42                              Radiologically, pseudocysts are drained externally using a percutaneous,
43                                Although most pseudocysts are not symptomatic and many resolve spontan
44 rphological parameters, including perifoveal pseudocysts, as prognostic factors for postoperative out
45  surgery in cases of pancreatic necrosis and pseudocyst assessed.
46 ocrine drainage who developed a large pelvic pseudocyst associated with a dilated pancreatic duct and
47 ning ductal anatomy when managing pancreatic pseudocysts associated with chronic pancreatitis.
48 ectrum of histology, including inflammatory (pseudocysts), benign (serous), premalignant (mucinous),
49 s between the gastrointestinal tract and the pseudocyst cavity.
50             Profound edema or formation of a pseudocyst containing plasma proteins is a prominent cha
51                             The percutaneous pseudocyst-cystostomy obviated the need for surgical rev
52 nitive treatment at the time of laparoscopy (pseudocyst debridement, ovarian cyst excision).
53                       In seven patients with pseudocysts, debris was seen in two (28%) at MR imaging
54                       However, patients with pseudocyst disease alone did better than other groups.
55                                              Pseudocyst disease is associated with the best outcome,
56 hese 103 patients, 56 underwent combined LPJ/pseudocyst drainage and 47 had LPJ alone.
57 ng therapeutic procedures such as endoscopic pseudocyst drainage and fine needle injection to treat p
58  Hemorrhagic complications during EUS-guided pseudocyst drainage can occur, because the vessels on th
59 lve or persist beyond 6 weeks, at which time pseudocyst drainage can safely be combined with cholecys
60 ed with either combined simultaneous LPJ and pseudocyst drainage or with LPJ alone.
61  that cannot be removed with use of standard pseudocyst drainage techniques.
62 rial bleeding precipitated during EUS-guided pseudocyst drainage which stopped instantaneously by pla
63 and surgical cystogastrostomy for pancreatic pseudocyst drainage, none of the patients in the endosco
64                     Compared to combined LPJ/pseudocyst drainage, the patients undergoing LPJ alone h
65  circulation near the pseudocyst wall during pseudocyst drainage, the placement of an expandable meta
66 and surgical cystogastrostomy for pancreatic pseudocyst drainage.
67 c fluid collections or pseudocysts until the pseudocysts either resolve or persist beyond 6 weeks, at
68 logically, adrenal cysts are subdivided into pseudocysts, endothelial cysts, epithelial cysts and par
69 rly cholecystectomy group required operative pseudocyst-enterostomy.
70 Data on demographics, clinical presentation, pseudocyst etiology and characteristics, diagnostic eval
71 aracterized by intense edema or formation of pseudocysts filled with plasma proteins, mainly albumin.
72 rrent methods for the drainage of pancreatic pseudocysts, focusing on the recent developments in the
73 gnificant decrease in the rate of pancreatic pseudocyst formation in patients who received PPI treatm
74 ith progression to pancreatic calcification, pseudocyst formation, endocrine and exocrine insufficien
75 ques for measuring trophozoite viability and pseudocyst formation, were used to screen the activity o
76 ch as pancreatic abscess and intrapancreatic pseudocyst have been abandoned.
77        Two hundred fifty-three patients with pseudocyst have been evaluated.
78 stectomy as well as management of pancreatic pseudocysts have been reported.
79 ded pancreatic necrosis, pancreatic abscess, pseudocyst, hemorrhagic pancreatitis, and pancreatic asc
80 fy septa within cystic neoplasms than within pseudocysts; however, the difference was not significant
81 ipancreatic fluid collections and subsequent pseudocyst in outcomes after cholecystectomy in these pa
82          SDOCT showed hyporeflective retinal pseudocysts in 13.6% of eyes.
83 doaneurysm of the splenic artery due to huge pseudocysts in a young alcoholic patient with recurrent
84 nefit of percutaneous drainage of pancreatic pseudocysts in unselected patients has not been realized
85 nage versus surgical treatment of pancreatic pseudocysts in unselected patients.
86 s of pancreatitis (eg, infected necrosis and pseudocysts) in particular subsets of patients.
87 een 32 and 82 years (mean=67 years), 14 with pseudocysts (infected in six cases) and 16 with encapsul
88 sts, nonoperative interventions performed on pseudocysts, intercurrent episodes of acute pancreatitis
89                     Simultaneous drainage of pseudocyst is not necessary.
90 resolve spontaneously over time, drainage of pseudocysts is occasionally required.
91 hey are often misdiagnosed as non-neoplastic pseudocysts leading to failed opportunities for curative
92 siderin deposition, pseudotumor-like growth, pseudocyst-like or multiloculated shape, vasogenic edema
93 c distortion of the fovea, which may include pseudocysts, macular schisis, cystoid macular edema, and
94 orrelation with the failure and successes of pseudocysts managed by percutaneous drainage as well as
95 creatitis, and recent data suggest that many pseudocysts may be observed or treated successfully by p
96 ause the vessels on the internal wall of the pseudocyst might be compressed by the fluid and thus not
97                     Treatment of symptomatic pseudocysts must be individualized, considering associat
98 lasms (n=15), serous cystadenomas (n=12), or pseudocysts (n=9), with confirmation of histologic diagn
99 holecystectomy, resolution or persistence of pseudocysts, nonoperative interventions performed on pse
100 dominal pain were associated with having had pseudocysts (odds ratio [OR] 9.48 [95% CI 3.01-35.49], p
101 ions of the pancreas and a caudal pancreatic pseudocyst of 39x24 mm.
102 dardized A-scan was consistent with multiple pseudocysts on pathological evaluation.
103 ent fluid collections, three abscesses, four pseudocysts, one hematoma, and one small-bowel and Roux-
104 esions (four endothelial cysts, three benign pseudocysts, one nonspecific benign cyst, one carcinoma,
105 ree methods for the drainage of a pancreatic pseudocyst, only the endoscopic approach can provide min
106  was defined as persistence of a symptomatic pseudocyst or the need for additional intervention other
107 of surgically correctable complications (eg, pseudocysts or biliary obstruction).
108 t malignancy) if causing pain, pancreatitis, pseudocysts or other complications.
109 ed mechanical ventilation, need for insulin, pseudocysts, or death was associated with older age (med
110 thickness (P = .031) and presence of retinal pseudocysts (P = .030).
111 atic fluid collections (APFC) and pancreatic pseudocysts (PPs), 75% (12/16) for walled-off necrosis (
112                    The primary end point was pseudocyst recurrence after a 24-month follow-up period.
113 e of the patients in the endoscopy group had pseudocyst recurrence during the follow-up period, there
114 ng-term pain relief was achieved in 90%, and pseudocyst recurrence was less than 1%.
115 tients who received endoscopic therapy had a pseudocyst recurrence, compared with 1 patient treated s
116               Of 20 patients with pancreatic pseudocysts, seven had pseudocysts that were identified
117 ent for peripancreatic fluid collections and pseudocysts should be made with careful assessment of th
118                                 Degenerative pseudocysts showed significantly lower circularity (0.68
119                                         Mean pseudocyst size was 4.2 +/- 1 cm, 8.2 +/- 1.1 cm, and 7.
120 macular hole stages, beginning with a foveal pseudocyst (stage 1A) and typically followed by disrupti
121 ients with pancreatic pseudocysts, seven had pseudocysts that were identified at pathologic resection
122 a with conventional percutaneous drainage, a pseudocyst-to-bladder drainage was performed.
123                     Patients with pancreatic pseudocysts underwent endoscopic (n = 20) or surgical cy
124 onstrate peripancreatic fluid collections or pseudocysts until the pseudocysts either resolve or pers
125 tandard technique for drainage of pancreatic pseudocysts, use of endoscopic methods is increasing.
126 cysts can be discriminated from degenerative pseudocysts using a quantitative multimodal imaging appr
127 3.3% in the bilateral group had intraretinal pseudocysts vs 10.2% in the unilateral group (p = 0.036,
128 leeding from collateral circulation near the pseudocyst wall during pseudocyst drainage, the placemen
129 s of patients with a diagnosis of pancreatic pseudocyst was performed from 1984 to 1995.
130                               The pancreatic pseudocyst was resorbed in eight months.
131 ameters, including the areas of intraretinal pseudocysts, was conducted.
132      Patients with a diagnosis of pancreatic pseudocyst were evaluated from 1985 to 2000.
133 reatitis and/or pathologic confirmation of a pseudocyst were excluded.
134   The six patients with localized abscess or pseudocyst were successfully treated with standard opera
135                                         Most pseudocysts were managed by percutaneous drainage, and a
136 ice with peripancreatic fluid collections or pseudocysts were monitored.
137 tibiotics; abscess formation was reduced and pseudocysts were smaller and less frequently infected.
138 ollow-up of 12 months, 1 patient developed a pseudocyst, which was successfully drained endoscopicall
139         Beginning in 1985, all patients with pseudocyst who were candidates for intervention (operati
140 patients with pancreatic cystic neoplasms or pseudocysts who underwent pancreatic MR imaging.
141                                              Pseudocysts with limited interruption of the underlying
142 m benign cystic lesions (serous cystadenomas+pseudocysts) with a 78% sensitivity at 80% specificity,
143  Various modalities are currently applied to pseudocysts, with little or no data to aid in the choice
144 lated morphology in cystic neoplasms than in pseudocysts, with the difference between these lesion ty

 
Page Top